GlassScriptPhysician profile
Jonathan A Metzger
NPI 1386954709
$523.36
in general payments reported to CMS, 2019-2025
8 companies · $26.88 in 2025
The $26.88 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.50 · 2022: $40.00 · 2023: $69.22 · 2024: $356 · 2025: $26.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $147.66 | 2023-2025 | Acumed, Acumed, Innate Implant |
| Ethicon US, LLC | $114.77 | 2021-2024 | Stratafix, Dermabond Prineo, Monocryl |
| Medtronic, INC. | $75.85 | 2024 | Plasmablade(Tm) |
| Stryker Corporation | $60.77 | 2024 | Aequalis Perform Reversed, Aequalis Perform |
| Pacira Pharmaceuticals Incorporated | $51.74 | 2023 | Iovera |
| Smith+Nephew, INC. | $30.86 | 2024 | Na, N/A |
| Invictus Surgical Incorporated | $28.33 | 2024 | |
| Heron Therapeutics, INC. | $13.38 | 2024 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Metzger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.